Publicaciones en colaboración con investigadores/as de Guy's Hospital (4)

2023

  1. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

    Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

  2. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    The Lancet, Vol. 401, Núm. 10373, pp. 269-280

2016

  1. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

    Haematologica, Vol. 101, Núm. 8, pp. 926-931

2015

  1. Conversion, correction, and international scale standardization: Results from a multicenter external quality assessment study for BCR-ABL1 testing

    Archives of Pathology and Laboratory Medicine, Vol. 139, Núm. 4, pp. 522-529